Sulkowski, Mark S <br/><br/>
Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections.  [electronic resource] 

 -  Hepatology (Baltimore, Md.)  Jan 2002 
 - 182-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0270-9139 
<br/><br/><label>Standard No.: </label>10.1053/jhep.2002.30319  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Alanine Transaminase--blood<br/>Alkynes<br/>Anti-HIV Agents--adverse effects<br/>Antiretroviral Therapy, Highly Active--adverse effects<br/>Aspartate Aminotransferases--blood<br/>Benzoxazines<br/>Bilirubin--blood<br/>Chemical and Drug Induced Liver Injury<br/>Cyclopropanes<br/>Female<br/>HIV Infections--drug therapy<br/>Hepatitis B--complications<br/>Hepatitis C--complications<br/>Humans<br/>Liver Diseases--diagnosis<br/>Male<br/>Nevirapine--adverse effects<br/>Oxazines--adverse effects<br/>Prospective Studies<br/>Reverse Transcriptase Inhibitors--adverse effects<br/>Risk Factors<br/>Treatment Outcome